Compass Therapeutics, Inc. - FORM 8-K - EX-16.1 - LETTER FROM RAICH ENDE MALTER & CO. LLP - June 23, 2020

Attached files

file filename
EX-10.14 - SUBLEASE AGREEMENT, DATED JULY 29, 2016. - Compass Therapeutics, Inc.ea123278ex10-14_compass.htm
EX-99.4 - PRESS RELEASE DATED JUNE 23, 2020 - Compass Therapeutics, Inc.ea123278ex99-4_compass.htm
EX-99.3 - UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS AS OF AND FOR THE FISCAL YEAR - Compass Therapeutics, Inc.ea123278ex99-3_compass.htm
EX-99.2 - UNAUDITED FINANCIAL STATEMENTS OF COMPASS THERAPEUTICS, LLC AS OF AND FOR THE QU - Compass Therapeutics, Inc.ea123278ex99-2_compass.htm
EX-99.1 - AUDITED FINANCIAL STATEMENTS OF COMPASS THERAPEUTICS, LLC AS OF AND FOR THE FISC - Compass Therapeutics, Inc.ea123278ex99-1_compass.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Compass Therapeutics, Inc.ea123278ex21-1_compass.htm
EX-10.15 - SUBLEASE MODIFICATION AGREEMENT, DATED JANUARY 17, 2018. - Compass Therapeutics, Inc.ea123278ex10-15_compass.htm
EX-10.13 - THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED OCTOBER 29, 2019. - Compass Therapeutics, Inc.ea123278ex10-13_compass.htm
EX-10.12 - SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED MARCH 8, 2019. - Compass Therapeutics, Inc.ea123278ex10-12_compass.htm
EX-10.11 - FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT, DATED SEPTEMBER 26, 2018. - Compass Therapeutics, Inc.ea123278ex10-11_compass.htm
EX-10.10 - LOAN AND SECURITY AGREEMENT, DATED MARCH 30, 2018. - Compass Therapeutics, Inc.ea123278ex10-10_compass.htm
EX-10.9 - AMENDED AND RESTATED COLLABORATION AGREEMENT, DATED FEBRUARY 11, 2015. - Compass Therapeutics, Inc.ea123278ex10-9_compass.htm
EX-10.8 - SUBSCRIPTION AGREEMENT, DATED JUNE 19, 2020. - Compass Therapeutics, Inc.ea123278ex10-8_compass.htm
EX-10.7 - REGISTRATION RIGHTS AGREEMENT, DATED JUNE 19, 2020. - Compass Therapeutics, Inc.ea123278ex10-7_compass.htm
EX-10.6 - FORM OF PRE-MERGER INDEMNIFICATION AGREEMENT (DIRECTORS AND EXECUTIVE OFFICERS) - Compass Therapeutics, Inc.ea123278ex10-6_compass.htm
EX-10.5 - FORM OF INDEMNIFICATION AGREEMENT (EXECUTIVE OFFICERS) - Compass Therapeutics, Inc.ea123278ex10-5_compass.htm
EX-10.4 - FORM OF INDEMNIFICATION AGREEMENT (DIRECTORS) - Compass Therapeutics, Inc.ea123278ex10-4_compass.htm
EX-10.3 - OFFER LETTER, DATED NOVEMBER 8, 2017, BETWEEN VERED BISKER-LEIB AND COMPASS THER - Compass Therapeutics, Inc.ea123278ex10-3_compass.htm
EX-10.2 - 2020 SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN - Compass Therapeutics, Inc.ea123278ex10-2_compass.htm
EX-10.1 - 2020 STOCK OPTION AND INCENTIVE PLAN - Compass Therapeutics, Inc.ea123278ex10-1_compass.htm
EX-3.3 - AMENDED AND RESTATED BYLAWS - Compass Therapeutics, Inc.ea123278ex3-3_compass.htm
EX-3.2 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Compass Therapeutics, Inc.ea123278ex3-2_compass.htm
EX-3.1 - CERTIFICATE OF MERGER - Compass Therapeutics, Inc.ea123278ex3-1_compass.htm
EX-2.1 - AGREEMENT AND PLAN OF MERGER, DATED JUNE 17, 2020. - Compass Therapeutics, Inc.ea123278ex2-1_compass.htm
8-K - CURRENT REPORT - Compass Therapeutics, Inc.ea123278-8k_compasstherap.htm

Exhibit 16.1

 

June 23, 2020

 

Securities and Exchange Commission

100 F Street NE

Washington, D.C. 20549

 

Ladies and Gentlemen:

 

We have read Item 4.01 of the Current Report on Form 8-K dated June 23, 2020 of Compass Therapeutics, Inc. and are in agreement with the statements in the paragraphs within that Item as they relate to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.

 

Respectfully submitted,

 

/s/ Raich Ende Malter & Co. LLP

 

New York, New York

Compass Therapeutics, Inc. Reports